139 related articles for article (PubMed ID: 10232930)
61. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
62. Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer.
Lacreta FP; Brennan JM; Nash SL; Comis RL; Tew KD; O'Dwyer PJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1186-91. PubMed ID: 7932170
[TBL] [Abstract][Full Text] [Related]
63. Pharmacokinetics of platinum following the administration of cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in dogs.
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1997; 17(5A):3681-3. PubMed ID: 9413223
[TBL] [Abstract][Full Text] [Related]
64. Myocardial disposition of amiodarone in the dog.
Latini R; Connolly SJ; Kates RE
J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
[TBL] [Abstract][Full Text] [Related]
65. The bioavailability and disposition of tiodazosin levulinate in beagle dogs with a comparison to prazosin hydrochloride.
Baughman RA; Mico BA; Benet LZ
Drug Metab Dispos; 1983; 11(2):143-6. PubMed ID: 6133719
[TBL] [Abstract][Full Text] [Related]
66. Pharmacokinetics of bromhexine in the dog.
Vandecasteele-Thienpont LM; Belpaire FM; Braeckman RA; De Leenheer AP
Arzneimittelforschung; 1980; 30(10):1643-5. PubMed ID: 7192102
[TBL] [Abstract][Full Text] [Related]
67. The effects of triethanolamine myristate, a fatty acid salt, on the bioavailability of riboflavin in dogs.
Forusz H; Ritschel WA
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):589-91. PubMed ID: 9010833
[TBL] [Abstract][Full Text] [Related]
68. Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog.
Payne JT; McCaw DL; Casteel SW; Frazier D; Rogers K; Tompson RV
Lasers Surg Med; 1996; 18(4):406-9. PubMed ID: 8732580
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of buflomedil after intravenous and oral administration.
Rey E; Barrier G; d'Athis P; de Lauture D; Richard MO; Lirzin JP; Sureau C; Olive G
Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):437-41. PubMed ID: 7203720
[TBL] [Abstract][Full Text] [Related]
70. The pharmacokinetics of 1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3,2-f)quinazoline, in dogs and rats after intravenous and oral administration.
Studenberg SD; Woolley JL; Deangelis DV; Wargin WA
Biopharm Drug Dispos; 1997 Jul; 18(5):433-42. PubMed ID: 9210981
[TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetic studies of the antiarrhythmic drugs ajmaline and N-propylajmaline bitartrate in dogs.
Anttila M; Tikkanen R; Nieminen L
Arzneimittelforschung; 1978; 28(3):397-9. PubMed ID: 580746
[TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetic study of aprindine and moxaprindine in dogs.
de Suray JM; Lavis A; Breekpot F
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
[TBL] [Abstract][Full Text] [Related]
73. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid.
Webber J; Kessel D; Fromm D
J Photochem Photobiol B; 1997 Jan; 37(1-2):151-3. PubMed ID: 9043101
[TBL] [Abstract][Full Text] [Related]
74. Pharmacodynamics and pharmacokinetics of dihydroergotamine (DHE) in conscious beagle dogs.
Müller-Schweinitzer E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):162-5. PubMed ID: 2459013
[TBL] [Abstract][Full Text] [Related]
75. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
[TBL] [Abstract][Full Text] [Related]
76. Chronopharmacokinetics of pentazocine in the beagle dog.
Ritschel WA; Bykadi G; Norman EJ; Lücker PW
Arzneimittelforschung; 1980; 30(9):1535-8. PubMed ID: 7193022
[TBL] [Abstract][Full Text] [Related]
77. Rectal bioavailability of lidocaine in the dog: evaluation of first-pass elimination.
Ritschel WA; Grummich KW; Hussain AS; Denson DD; Ritschel BE
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):497-502. PubMed ID: 3695734
[TBL] [Abstract][Full Text] [Related]
78. Pharmacokinetic profile of idazoxan in the beagle dog.
Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
J Pharm Pharmacol; 1989 Jun; 41(6):384-7. PubMed ID: 2570833
[TBL] [Abstract][Full Text] [Related]
79. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.
Hussain MA; Aungst BJ; Lam G; Shefter E
Biopharm Drug Dispos; 1987; 8(5):497-505. PubMed ID: 3663885
[TBL] [Abstract][Full Text] [Related]
80. Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs.
Uemura Y; Tanaka S; Ida S; Yuzuriha T
J Pharm Pharmacol; 1993 Dec; 45(12):1077-81. PubMed ID: 7908977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
